October 2, 2025 · Form 4 insider transaction
Khattar Jack A. bought 20,000 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 19, 2021.